Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Risk Stratification for Sudden Cardiac Death in Non-Ischaemic Dilated Cardiomyopathy
Mohammed Akhtar, Perry Elliott
Current Cardiology Reports (2019) Vol. 21, Iss. 12
Open Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the state of genetic testing for cardiac diseases
Arthur A.M. Wilde, Christopher Semsarian, Manlio F. Márquez, et al.
EP Europace (2022) Vol. 24, Iss. 8, pp. 1307-1367
Open Access | Times Cited: 258
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the State of Genetic Testing for Cardiac Diseases
Arthur A.M. Wilde, Christopher Semsarian, Manlio F. Márquez, et al.
Heart Rhythm (2022) Vol. 19, Iss. 7, pp. e1-e60
Open Access | Times Cited: 158
Assessment of the Diagnostic Yield of Combined Cardiomyopathy and Arrhythmia Genetic Testing
Lisa Dellefave‐Castillo, Allison L. Cirino, Thomas E. Callis, et al.
JAMA Cardiology (2022) Vol. 7, Iss. 9, pp. 966-966
Open Access | Times Cited: 54
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the state of genetic testing for cardiac diseases
Arthur A.M. Wilde, Christopher Semsarian, Manlio F. Márquez, et al.
Journal of Arrhythmia (2022) Vol. 38, Iss. 4, pp. 491-553
Open Access | Times Cited: 41
Bacterial etiology and mortality rate in community-acquired pneumonia, healthcare-associated pneumonia and hospital-acquired pneumonia in Thai university hospital
Jaturon Poovieng, Boonsub Sakboonyarat, Worapong Nasomsong
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 22
Post-mortem genetic testing in sudden cardiac death and genetic screening of relatives at risk: lessons learned from a Czech pilot multidisciplinary study
Pavel Votýpka, Alice Krebsová, Patricia Norambuena-Poustková, et al.
International Journal of Legal Medicine (2023) Vol. 137, Iss. 6, pp. 1787-1801
Open Access | Times Cited: 11
Diagnosis and Risk Prediction of Dilated Cardiomyopathy in the Era of Big Data and Genomics
Arjan Sammani, Annette F. Baas, Folkert W. Asselbergs, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 5, pp. 921-921
Open Access | Times Cited: 25
Left Bundle Branch Block-associated Cardiomyopathy: A New Approach
Shunmuga Sundaram Ponnusamy, Pugazhendhi Vijayaraman, Kenneth A. Ellenbogen
Arrhythmia & Electrophysiology Review (2024) Vol. 13
Open Access | Times Cited: 3
Human Cell Modeling for Cardiovascular Diseases
Melania Lippi, Ilaria Stadiotti, Giulio Pompilio, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 17, pp. 6388-6388
Open Access | Times Cited: 25
A novel risk model for predicting potentially life-threatening arrhythmias in non-ischemic dilated cardiomyopathy (DCM-SVA risk)
Elham Kayvanpour, Arjan Sammani, Farbod Sedaghat‐Hamedani, et al.
International Journal of Cardiology (2021) Vol. 339, pp. 75-82
Open Access | Times Cited: 19
CMR-Based Risk Stratification of Sudden Cardiac Death and Use of Implantable Cardioverter–Defibrillator in Non-Ischemic Cardiomyopathy
Laura Keil, Céleste Chevalier, Paulus Kirchhof, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 7115-7115
Open Access | Times Cited: 17
Time-dependent S-wave areas predict sudden cardiac death risk: a prospective, multicentre registered study
Xin‐Feng Wang, Wenhao Liu, Ziheng Zheng, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 2
Assessment of ICD eligibility in non-ischaemic cardiomyopathy patients: a position statement by the Task Force of the Dutch Society of Cardiology
Anne‐Lotte C.J. van der Lingen, Tom E. Verstraelen, Lieselot van Erven, et al.
Netherlands Heart Journal (2024) Vol. 32, Iss. 5, pp. 190-197
Open Access | Times Cited: 2
Implantable Cardiac Devices in Patients with Brady- and Tachy-Arrhythmias: An Update of the Literature
William L. Chick, Christopher Monkhouse, Amal Muthumala, et al.
Reviews in Cardiovascular Medicine (2024) Vol. 25, Iss. 5
Open Access | Times Cited: 2
Characterization and natural history of patients with LMNA‐related dilated cardiomyopathy in the phase 3 REALM‐DCM trial
Pablo García‐Pavía, Neal K. Lakdawala, Gianfranco Sinagra, et al.
ESC Heart Failure (2024) Vol. 11, Iss. 6, pp. 4201-4208
Open Access | Times Cited: 2
A machine learning-assisted model for renal urate underexcretion with genetic and clinical variables among Chinese men with gout
Mingshu Sun, Wenyan Sun, Xuetong Zhao, et al.
Arthritis Research & Therapy (2022) Vol. 24, Iss. 1
Open Access | Times Cited: 11
A pilot study of S100A4, S100A8/A9, and S100A12 in dilated cardiomyopathy: novel biomarkers for diagnosis or prognosis?
Ying Yu, Hui Shi, Yucheng Wang, et al.
ESC Heart Failure (2023) Vol. 11, Iss. 1, pp. 503-512
Open Access | Times Cited: 6
The Role of AI in Characterizing the DCM Phenotype
Clint Asher, Esther Puyol‐Antón, Maleeha Rizvi, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 11
QiShenYiQi pill for myocardial collagen metabolism and apoptosis in rats of autoimmune cardiomyopathy
Shichao Lv, Wanqin Zhang, Peng Yuan, et al.
Pharmaceutical Biology (2022) Vol. 60, Iss. 1, pp. 722-728
Open Access | Times Cited: 8
Characterization of Non-Ischemic Dilated Cardiomyopathy in a Native Tanzanian Cohort: MOYO Study
Lulu Fundikira, Pilly Chillo, Mohamed Zahir Alimohamed, et al.
Global Heart (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 1
Well-Known and Novel Serum Biomarkers for Risk Stratification of Patients with Non-ischemic Dilated Cardiomyopathy
Larisa Anghel, Radu Andy Sascău, Ioana Mădălina Zota, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5688-5688
Open Access | Times Cited: 9
Histone deacetylase 2-dependent ventricular electrical remodeling in a porcine model of early heart failure
Pascal Syren, Ann‐Kathrin Rahm, Patrick A. Schweizer, et al.
Life Sciences (2021) Vol. 281, pp. 119769-119769
Closed Access | Times Cited: 9
Electrical Ventricular Remodeling in Dilated Cardiomyopathy
Christine Mages, Heike Gampp, Pascal Syren, et al.
Cells (2021) Vol. 10, Iss. 10, pp. 2767-2767
Open Access | Times Cited: 9
Preventive implantable cardioverter defibrillator therapy in contemporary clinical practice: need for more stringent selection criteria
Jaap W. Deckers, Banafsheh Arshi, Jan C. van den Berge, et al.
ESC Heart Failure (2021) Vol. 8, Iss. 5, pp. 3656-3662
Open Access | Times Cited: 7
Downgrade of cardiac defibrillator devices to pacemakers in elderly heart failure patients: clinical considerations and the importance of shared decision-making
Hessel F. Groenveld, Jenifer E. Coster, Dirk J. van Veldhuisen, et al.
Netherlands Heart Journal (2021) Vol. 29, Iss. 5, pp. 243-252
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top